• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

GoodRx Offers Up to 43% Discounts on Fertility Treatments, Launches Fertility Hub for Patient Supports

by Jasmine Pennic 05/22/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
GoodRx Offers Up to 43% Discounts on Fertility Treatments, Launches Fertility Hub for Patient Supports

What You Should Know: 

– GoodRx, a leading platform for prescription medication savings, announced today it’s offering significant discounts of up to 43% on fertility treatments based on the best available GoodRx price. This move aims to help families and individuals manage the often-prohibitive costs associated with in vitro fertilization (IVF) and other fertility treatments.

– By offering substantial discounts and educational resources, GoodRx is committed to making fertility care more accessible. 

Easing the Financial Burden of Fertility Care

The high cost of fertility treatments is a major barrier for many seeking to expand their families. A single IVF cycle can range from $15,000 to $30,000, with medication costs representing a significant portion of this expense. Many medications used during IVF cycles require individual dosing, further adding to the financial burden. Additionally, with success rates often requiring multiple cycles, the total cost can quickly become overwhelming.

While insurance coverage for fertility treatments is increasing, it rarely covers the entire cost. GoodRx’s discounts aim to bridge this gap, offering savings of up to 43% on generic and brand-name medications used throughout the IVF process.

GoodRx Fertility Hub: Empowering Patients on Their Journey

Understanding the complexities of fertility medications and the IVF process can be daunting. To support individuals navigating fertility treatments, GoodRx has launched the GoodRx Fertility Hub. This comprehensive online resource provides:

  • Credible Information: Easy-to-understand articles address common fertility concerns, treatment options, and the IVF process itself.
  • Actionable Insights: The Hub provides practical guidance to help patients navigate their fertility journey.
  • Trusted Expertise: Content is researched and written by a team of editorial and medical experts, including doctors and pharmacists.
“Hundreds of thousands of people every year are faced with an incredibly challenging decision: do I reevaluate my plans to expand my family, or pay thousands of dollars to pursue fertility treatments? GoodRx is here to relieve some of that financial burden and take some of the stress out of the reproductive journey,” said Dorothy Gemmell, Chief Commercial Officer, GoodRx. “Through savings on both generic and brand-name medications, GoodRx helps users afford their fertility treatments so fewer people have to choose between their future and their finances.”

Individuals seeking to learn more or explore GoodRx’s fertility savings opportunities can download the GoodRx app or visit their website at https://www.goodrx.com/go/fertility.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |